Ratings by Stifel (James Condulis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Amylyx Pharmaceuticals inc. | AMLX | New Coverage | Buy (N/A) |
15.17 (13.85) |
-8.7% | Details | |
| 3/2/2026 | Aardvark Therapeutics Inc | AARD | Downgrade | Hold (Buy) |
12.50 (5.85) |
-53.2% | Details | |
| 2/26/2026 | Edgewise Therapeutics | EWTX | Maintain | Hold (N/A) |
|
Details | ||
| 2/26/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 12/16/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
3.25 (3.76) |
15.69% | Details | |
| 11/14/2025 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (Buy) |
|
Details | ||
| 11/5/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | Aardvark Therapeutics Inc | AARD | New Coverage | Buy (N/A) |
12.67 (12.50) |
-1.34% | Details | |
| 9/24/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 9/2/2025 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Mirum Pharmaceuticals | MIRM | New Coverage | Buy (N/A) |
59.97 (86.21) |
43.76% | Details | |
| 8/7/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 7/7/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Edgewise Therapeutics | EWTX | Maintain | Hold (N/A) |
|
Details | ||
| 6/12/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Buy (Buy) |
|
Details | ||
| 6/10/2025 | NewAmsterdam Pharma Co NV | NAMS | New Coverage | Buy (N/A) |
20.14 (29.86) |
48.26% | Details | |
| 5/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 4/21/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | Soleno Therapeutics Inc. | SLNO | New Coverage | Buy (N/A) |
44.44 (39.68) |
-10.71% | Details | |
| 2/18/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 1/22/2025 | Edgewise Therapeutics | EWTX | New Coverage | Hold (N/A) |
26.26 (27.82) |
5.94% | Details | |
| 1/22/2025 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
45.74 (60.41) |
32.07% | Details |
